94 related articles for article (PubMed ID: 9472098)
1. Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours.
Mimori K; Mori M; Shiraishi T; Tanaka S; Haraguchi M; Ueo H; Shirasaka C; Akiyoshi T
Int J Oncol; 1998 Mar; 12(3):597-601. PubMed ID: 9472098
[TBL] [Abstract][Full Text] [Related]
2. Analysis of ornithine decarboxylase messenger ribonucleic acid expression in colorectal carcinoma.
Mimori K; Mori M; Shiraishi T; Fujie T; Baba K; Kusumoto H; Haraguchi M; Ueo H; Akiyoshi T
Dis Colon Rectum; 1997 Sep; 40(9):1095-100. PubMed ID: 9293942
[TBL] [Abstract][Full Text] [Related]
3. Detection of ornithine decarboxylase mRNA in human breast cancer MCF-7 cells by in situ RT-PCR.
Clerico L; Mancuso T; Crovella S; Amoroso A; Morgutti M; Demori E; Parodi S
Int J Oncol; 2000 Feb; 16(2):241-4. PubMed ID: 10639565
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.
Mafune K; Tanaka Y; Mimori K; Mori M; Takubo K; Makuuchi M
Clin Cancer Res; 1999 Dec; 5(12):4073-8. PubMed ID: 10632342
[TBL] [Abstract][Full Text] [Related]
5. Expression of ornithine decarboxylase mRNA in gastric carcinoma.
Mori M; Honda M; Shibuta K; Baba K; Nakashima H; Haraguchi M; Koba F; Ueo H; Sugimachi K; Akiyoshi T
Cancer; 1996 Apr; 77(8 Suppl):1634-8. PubMed ID: 8608555
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma.
Inoue H; Mimori K; Shiraishi T; Kataoka A; Sadanaga N; Ueo H; Barnard GF; Mori M
Oncol Rep; 2000; 7(4):871-4. PubMed ID: 10854560
[TBL] [Abstract][Full Text] [Related]
7. Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer.
Glikman P; Vegh I; Pollina MA; Mosto AH; Levy CM
Cancer; 1987 Nov; 60(9):2237-43. PubMed ID: 3440234
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.
Cañizares F; Salinas J; de las Heras M; Diaz J; Tovar I; Martinez P; Peñafiel R
Clin Cancer Res; 1999 Aug; 5(8):2035-41. PubMed ID: 10473083
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of MT1-MMP mRNA expression in breast cancer.
Mimori K; Ueo H; Shirasaka C; Mori M
Oncol Rep; 2001; 8(2):401-3. PubMed ID: 11182063
[TBL] [Abstract][Full Text] [Related]
10. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
Lin CK; Zou HY; Kaptein JS; Yen CF; Kalunta CI; Nguyen TT; Park E; Lad PM
Exp Cell Res; 1997 Nov; 237(1):231-41. PubMed ID: 9417887
[TBL] [Abstract][Full Text] [Related]
11. Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma.
Dexter DW; Reddy RK; Geles KG; Bansal S; Myint MA; Rogakto A; Leighton JC; Goldstein LJ
Clin Cancer Res; 1998 Jun; 4(6):1533-42. PubMed ID: 9626474
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
Bièche I; Noguès C; Paradis V; Olivi M; Bedossa P; Lidereau R; Vidaud M
Clin Cancer Res; 2000 Feb; 6(2):452-9. PubMed ID: 10690523
[TBL] [Abstract][Full Text] [Related]
13. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
Yasojima H; Shimomura A; Naoi Y; Kishi K; Baba Y; Shimazu K; Nakayama T; Kim SJ; Tamaki Y; Noguchi S
Eur J Cancer; 2011 Aug; 47(12):1779-88. PubMed ID: 21741827
[TBL] [Abstract][Full Text] [Related]
14. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Danenberg KD; Danenberg PV; Hölscher AH; Brabender J
Clin Lung Cancer; 2010 Mar; 11(2):114-9. PubMed ID: 20199977
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin mRNA expression in breast carcinomas correlates with overall and disease-free survival.
Guriec N; Marcellin L; Gairard B; Caldéroli H; Wilk A; Renaud R; Bergerat JP; Oberling F
Invasion Metastasis; 1996; 16(1):19-26. PubMed ID: 8830762
[TBL] [Abstract][Full Text] [Related]
16. N-myc protein expression in human breast carcinoma: prognostic implications.
Mizukami Y; Nonomura A; Takizawa T; Noguchi M; Michigishi T; Nakamura S; Ishizaki T
Anticancer Res; 1995; 15(6B):2899-905. PubMed ID: 8669886
[TBL] [Abstract][Full Text] [Related]
17. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
[TBL] [Abstract][Full Text] [Related]
20. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
